Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is associated with adverse left ventricular (LV) remodeling causing dysfunction and malignant arrhythmias. Severely affected patients present with disease onset during childhood and sudden cardiac death risk (SCD) stratification is of the highest importance in this...
Guardado en:
Autores principales: | Kathrin Pollmann, Emanuel Kaltenecker, Julia Schleihauf, Peter Ewert, Agnes Görlach, Cordula M. Wolf |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56fe6d338de242908ba8135881ab8790 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of the Serum Peptidomics Profile for Cats With Sarcomeric Gene Mutation and Hypertrophic Cardiomyopathy
por: Pratch Sukumolanan, et al.
Publicado: (2021) -
iN-VITRO INTERACTION STUDIES OF VERAPAMIL WITH FLUOROQUINOLONES USING FIRST ORDER DERIVATIVE UV SPECTROPHOTOMETRY AND RP-HPLC
por: SULTANA,NAJMA, et al.
Publicado: (2011) -
Recent Findings Related to Cardiomyopathy and Genetics
por: Takanobu Yamada, et al.
Publicado: (2021) -
Management of Hypertrophic Cardiomyopathy
por: Alan D. Enriquez, et al.
Publicado: (2014) -
Hypertrophic cardiomyopathy: a modern view of the problem
por: Amina M. Alieva, et al.
Publicado: (2020)